{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T06:15:01Z","timestamp":1788156901366,"version":"build-2803163510"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T00:00:00Z","timestamp":1788134400000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82303343"],"award-info":[{"award-number":["82303343"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["32370973"],"award-info":[{"award-number":["32370973"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Henan Medical Science and Technology Joint Building Program","award":["LHGJ20250307"],"award-info":[{"award-number":["LHGJ20250307"]}]},{"DOI":"10.13039\/501100006407","name":"Natural Science Foundation of Henan Province","doi-asserted-by":"publisher","award":["252300421432"],"award-info":[{"award-number":["252300421432"]}],"id":[{"id":"10.13039\/501100006407","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Henan Province Young and middle-aged Health Science and Technology Innovation talents Training Project","award":["JQRC2025011"],"award-info":[{"award-number":["JQRC2025011"]}]},{"name":"Central Plains Science and Technology Innovation Young Top Talents Project"},{"name":"College Students' Innovative Entrepreneurial Training Plan Program","award":["2025cxcy874"],"award-info":[{"award-number":["2025cxcy874"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-026-04995-x","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T13:54:58Z","timestamp":1788011698000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reprogramming pulmonary B cells by ANXA1 silencing halts lung metastatic niche formation in breast cancer"],"prefix":"10.1186","volume":"24","author":[{"given":"Xiaoke","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohan","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixi","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningjing","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hefei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinkun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihai","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4708-1816","authenticated-orcid":false,"given":"Fazhan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,29]]},"reference":[{"key":"4995_CR1","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12943-025-02318-6","volume":"24","author":"G Xiao","year":"2025","unstructured":"Xiao G, Wang X, Xu Z, Liu Y, Jing J. Lung-specific metastasis: the coevolution of tumor cells and lung microenvironment. Mol Cancer. 2025;24:118. https:\/\/doi.org\/10.1186\/s12943-025-02318-6.","journal-title":"Mol Cancer"},{"key":"4995_CR2","doi-asserted-by":"publisher","first-page":"e242174","DOI":"10.1001\/jamanetworkopen.2024.2174","volume":"7","author":"T Berg","year":"2024","unstructured":"Berg T, Jensen M-B, Rossing M, Bechmann T, Donskov F, Knoop AS, et al. Development and Methodological Validation of a Modified Staging System for de Novo Metastatic Breast Cancer. JAMA Netw Open. 2024;7:e242174. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.2174.","journal-title":"JAMA Netw Open"},{"key":"4995_CR3","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41572-025-00642-1","volume":"11","author":"L Zullo","year":"2025","unstructured":"Zullo L, Filippiadis D, Hendriks LEL, Portik D, Spicer JD, Wistuba II, et al. Lung metastases. Nat Rev Dis Primers. 2025;11:60. https:\/\/doi.org\/10.1038\/s41572-025-00642-1.","journal-title":"Nat Rev Dis Primers"},{"key":"4995_CR4","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.ccell.2023.02.018","volume":"41","author":"L Patras","year":"2023","unstructured":"Patras L, Shaashua L, Matei I, Lyden D. Immune determinants of the pre-metastatic niche. Cancer Cell. 2023;41:546\u201372. https:\/\/doi.org\/10.1016\/j.ccell.2023.02.018.","journal-title":"Cancer Cell"},{"key":"4995_CR5","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41392-024-01937-7","volume":"9","author":"Y Wang","year":"2024","unstructured":"Wang Y, Jia J, Wang F, Fang Y, Yang Y, Zhou Q, et al. Pre-metastatic niche: formation, characteristics and therapeutic implication. Signal Transduct Target Ther. 2024;9:236. . https:\/\/doi.org\/10.1038\/s41392-024-01937-7","journal-title":"Signal Transduct Target Ther"},{"key":"4995_CR6","doi-asserted-by":"publisher","first-page":"eadd5028","DOI":"10.1126\/sciadv.add5028","volume":"9","author":"C Riera-Domingo","year":"2023","unstructured":"Riera-Domingo C, Leite-Gomes E, Charatsidou I, Zhao P, Carr\u00e1 G, Cappellesso F, et al. Breast tumors interfere with endothelial TRAIL at the premetastatic niche to promote cancer cell seeding. Sci Adv. 2023;9:eadd5028. . https:\/\/doi.org\/10.1126\/sciadv.add5028","journal-title":"Sci Adv"},{"key":"4995_CR7","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1158\/2159-8290.CD-24-0002","volume":"14","author":"J Prakash","year":"2024","unstructured":"Prakash J, Shaked Y. The Interplay between Extracellular Matrix Remodeling and Cancer Therapeutics. Cancer Discov. 2024;14:1375\u201388. https:\/\/doi.org\/10.1158\/2159-8290.CD-24-0002.","journal-title":"Cancer Discov"},{"key":"4995_CR8","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1016\/j.ccell.2024.05.004","volume":"42","author":"CS McGinnis","year":"2024","unstructured":"McGinnis CS, Miao Z, Superville D, Yao W, Goga A, Reticker-Flynn NE, et al. The temporal progression of lung immune remodeling during breast cancer metastasis. Cancer Cell. 2024;42:1018\u2013e10316. . https:\/\/doi.org\/10.1016\/j.ccell.2024.05.004","journal-title":"Cancer Cell"},{"key":"4995_CR9","doi-asserted-by":"publisher","first-page":"4790","DOI":"10.1038\/s41467-023-40478-5","volume":"14","author":"J Wang","year":"2023","unstructured":"Wang J, Ocadiz-Ruiz R, Hall MS, Bushnell GG, Orbach SM, Decker JT, et al. A synthetic metastatic niche reveals antitumor neutrophils drive breast cancer metastatic dormancy in the lungs. Nat Commun. 2023;14:4790. . https:\/\/doi.org\/10.1038\/s41467-023-40478-5","journal-title":"Nat Commun"},{"key":"4995_CR10","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/s41586-025-09332-0","volume":"645","author":"SB Chia","year":"2025","unstructured":"Chia SB, Johnson BJ, Hu J, Valen\u00e7a-Pereira F, Chadeau-Hyam M, Guntoro F, et al. Respiratory viral infections awaken metastatic breast cancer cells in lungs. Nat Nat. 2025;645:496\u2013506. . https:\/\/doi.org\/10.1038\/s41586-025-09332-0","journal-title":"Nat Nat"},{"key":"4995_CR11","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12943-026-02645-2","volume":"25","author":"X-R Zhang","year":"2026","unstructured":"Zhang X-R, Wei B, Jiang B-H, Ren W-H. The pre-metastatic niche: mechanisms, heterogeneity, and therapeutic opportunities. Mol Cancer. 2026;25:117. https:\/\/doi.org\/10.1186\/s12943-026-02645-2.","journal-title":"Mol Cancer"},{"key":"4995_CR12","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1158\/0008-5472.CAN-23-0620","volume":"83","author":"MJ Ramos","year":"2023","unstructured":"Ramos MJ, Lui AJ, Hollern DP. The Evolving Landscape of B Cells in Cancer Metastasis. Cancer Res. 2023;83:3835\u201345. https:\/\/doi.org\/10.1158\/0008-5472.CAN-23-0620.","journal-title":"Cancer Res"},{"key":"4995_CR13","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41423-026-01422-x","volume":"23","author":"SL Nutt","year":"2026","unstructured":"Nutt SL, Tellier J, Da Gama Duarte J. Defining the rules of engagement: B cells, antibodies and cancer control. Cell Mol Immunol. 2026;23:607\u201318. https:\/\/doi.org\/10.1038\/s41423-026-01422-x.","journal-title":"Cell Mol Immunol"},{"key":"4995_CR14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41392-024-01765-9","volume":"9","author":"A Hu","year":"2024","unstructured":"Hu A, Sun L, Lin H, Liao Y, Yang H, Mao Y. Harnessing innate immune pathways for therapeutic advancement in cancer. Signal Transduct Target Ther. 2024;9:68. . https:\/\/doi.org\/10.1038\/s41392-024-01765-9","journal-title":"Signal Transduct Target Ther"},{"key":"4995_CR15","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1158\/2326-6066.CIR-22-0896","volume":"11","author":"D Xiao","year":"2023","unstructured":"Xiao D, Zeng T, Zhu W, Yu Z-Z, Huang W, Yi H, et al. ANXA1 Promotes Tumor Immune Evasion by Binding PARP1 and Upregulating Stat3-Induced Expression of PD-L1 in Multiple Cancers. Cancer Immunol Res. 2023;11:1367\u201383. . https:\/\/doi.org\/10.1158\/2326-6066.CIR-22-0896","journal-title":"Cancer Immunol Res"},{"key":"4995_CR16","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12974-021-02174-3","volume":"18","author":"X Xu","year":"2021","unstructured":"Xu X, Gao W, Li L, Hao J, Yang B, Wang T, et al. Annexin A1 protects against cerebral ischemia\u2013reperfusion injury by modulating microglia\/macrophage polarization via FPR2\/ALX-dependent AMPK-mTOR pathway. J Neuroinflamm. 2021;18:119. . https:\/\/doi.org\/10.1186\/s12974-021-02174-3","journal-title":"J Neuroinflamm"},{"key":"4995_CR17","doi-asserted-by":"publisher","first-page":"6340","DOI":"10.1073\/pnas.0913360107","volume":"107","author":"M De Graauw","year":"2010","unstructured":"De Graauw M, Van Miltenburg MH, Schmidt MK, Pont C, Lalai R, Kartopawiro J, et al. Annexin A1 regulates TGF-beta signaling and promotes metastasis formation of basal-like breast cancer cells. Proc Natl Acad Sci. 2010;107:6340\u20135. https:\/\/doi.org\/10.1073\/pnas.0913360107.","journal-title":"Proc Natl Acad Sci"},{"key":"4995_CR18","doi-asserted-by":"publisher","first-page":"e006345","DOI":"10.1136\/jitc-2022-006345","volume":"11","author":"Z-Z Yu","year":"2023","unstructured":"Yu Z-Z, Liu Y-Y, Zhu W, Xiao D, Huang W, Lu S-S, et al. ANXA1-derived peptide for targeting PD-L1 degradation inhibits tumor immune evasion in multiple cancers. J ImmunoTher Cancer. 2023;11:e006345. https:\/\/doi.org\/10.1136\/jitc-2022-006345.","journal-title":"J ImmunoTher Cancer"},{"key":"4995_CR19","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/s41388-023-02919-9","volume":"43","author":"HN Al-Ali","year":"2024","unstructured":"Al-Ali HN, Crichton SJ, Fabian C, Pepper C, Butcher DR, Dempsey FC, et al. A therapeutic antibody targeting annexin-A1 inhibits cancer cell growth in vitro and in vivo. Oncogene. 2024;43:608\u201314. . https:\/\/doi.org\/10.1038\/s41388-023-02919-9","journal-title":"Oncogene"},{"key":"4995_CR20","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1038\/s41416-020-01066-2","volume":"123","author":"M Nonaka","year":"2020","unstructured":"Nonaka M, Suzuki-Anekoji M, Nakayama J, Mabashi-Asazuma H, Jarvis DL, Yeh J-C, et al. Overcoming the blood\u2013brain barrier by Annexin A1-binding peptide to target brain tumours. Br J Cancer. 2020;123:1633\u201343. . https:\/\/doi.org\/10.1038\/s41416-020-01066-2","journal-title":"Br J Cancer"},{"key":"4995_CR21","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12885-020-07760-x","volume":"21","author":"T Yoneyama","year":"2021","unstructured":"Yoneyama T, Hatakeyama S, Sutoh Yoneyama M, Yoshiya T, Uemura T, Ishizu T, et al. Tumor vasculature-targeted 10B delivery by an Annexin A1-binding peptide boosts effects of boron neutron capture therapy. BMC Cancer. 2021;21:72. https:\/\/doi.org\/10.1186\/s12885-020-07760-x.","journal-title":"BMC Cancer"},{"key":"4995_CR22","doi-asserted-by":"publisher","first-page":"e0241157","DOI":"10.1371\/journal.pone.0241157","volume":"16","author":"M Nonaka","year":"2021","unstructured":"Nonaka M, Mabashi-Asazuma H, Jarvis DL, Yamasaki K, Akama TO, Nagaoka M, et al. Development of an orally-administrable tumor vasculature-targeting therapeutic using annexin A1-binding D-peptides. PLOS One. 2021;16:e0241157. https:\/\/doi.org\/10.1371\/journal.pone.0241157","journal-title":"PLOS One"},{"key":"4995_CR23","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/imm.13455","volume":"166","author":"L Kelly","year":"2022","unstructured":"Kelly L, McGrath S, Rodgers L, McCall K, Tulunay Virlan A, Dempsey F, et al. Annexin-A1: The culprit or the solution? Immunology. 2022;166:2\u201316. https:\/\/doi.org\/10.1111\/imm.13455.","journal-title":"Immunology"},{"key":"4995_CR24","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41573-024-00912-9","volume":"23","author":"Q Tang","year":"2024","unstructured":"Tang Q, Khvorova A. RNAi-based drug design: considerations and future directions. Nat Rev Drug Discovery. 2024;23:341\u201364. https:\/\/doi.org\/10.1038\/s41573-024-00912-9.","journal-title":"Nat Rev Drug Discovery"},{"key":"4995_CR25","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1038\/s41587-023-02105-y","volume":"42","author":"V Jadhav","year":"2024","unstructured":"Jadhav V, Vaishnaw A, Fitzgerald K, Maier MA. RNA interference in the era of nucleic acid therapeutics. Nat Biotechnol. 2024;42:394\u2013405. https:\/\/doi.org\/10.1038\/s41587-023-02105-y.","journal-title":"Nat Biotechnol"},{"key":"4995_CR26","doi-asserted-by":"publisher","unstructured":"Ma Y, Li S, Lin X, Chen Y. A perspective of lipid nanoparticles for RNA delivery. Exploration. 2024;4:20230147. https:\/\/doi.org\/10.1002\/EXP.20230147","DOI":"10.1002\/EXP.20230147"},{"key":"4995_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41551-026-01615-9","author":"Z Tian","year":"2026","unstructured":"Tian Z, Wang X, Chatterjee S, Miller W, Guerrero E, Sung Y-C, et al. Tripod-like lung-targeting (LuT) lipids for highly efficient and selective LNPs for gene delivery and editing. Nat Biomed Eng [Internet]. 2026. https:\/\/doi.org\/10.1038\/s41551-026-01615-9.","journal-title":"Nat Biomed Eng [Internet]"},{"key":"4995_CR28","doi-asserted-by":"publisher","first-page":"115446","DOI":"10.1016\/j.addr.2024.115446","volume":"214","author":"K Mrksich","year":"2024","unstructured":"Mrksich K, Padilla MS, Mitchell MJ. Breaking the final barrier: Evolution of cationic and ionizable lipid structure in lipid nanoparticles to escape the endosome. Adv Drug Delivery Rev. 2024;214:115446. https:\/\/doi.org\/10.1016\/j.addr.2024.115446.","journal-title":"Adv Drug Delivery Rev"},{"key":"4995_CR29","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.apsb.2021.08.011","volume":"12","author":"Y Yan","year":"2022","unstructured":"Yan Y, Du C, Duan X, Yao X, Wan J, Jiang Z, et al. Inhibiting collagen I production and tumor cell colonization in the lung via miR-29a-3p loading of exosome-\/liposome-based nanovesicles. Acta Pharm Sinica B. 2022;12:939\u201351. https:\/\/doi.org\/10.1016\/j.apsb.2021.08.011.","journal-title":"Acta Pharm Sinica B"},{"key":"4995_CR30","doi-asserted-by":"publisher","first-page":"100082","DOI":"10.1016\/j.ntm.2025.100082","volume":"4","author":"MAJ Shaikh","year":"2025","unstructured":"Shaikh MAJ, Goyal K, Afzal M, Roopashree R, Kumari M, Krithiga T, et al. Liposome-encapsulated therapies: Precision medicine for inflammatory lung disorders. Nano TransMed. 2025;4:100082. https:\/\/doi.org\/10.1016\/j.ntm.2025.100082.","journal-title":"Nano TransMed"},{"key":"4995_CR31","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/ctm2.24","volume":"10","author":"F Tang","year":"2020","unstructured":"Tang F, Tie Y, Tu C, Wei X. Surgical trauma-induced immunosuppression in cancer: Recent advances and the potential therapies. Clin Transl Med. 2020;10:199\u2013223. https:\/\/doi.org\/10.1002\/ctm2.24.","journal-title":"Clin Transl Med"},{"key":"4995_CR32","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41571-019-0319-9","volume":"17","author":"P Matzner","year":"2020","unstructured":"Matzner P, Sandbank E, Neeman E, Zmora O, Gottumukkala V, Ben-Eliyahu S. Harnessing cancer immunotherapy during the unexploited immediate perioperative period. Nat Rev Clin Oncol. 2020;17:313\u201326. https:\/\/doi.org\/10.1038\/s41571-019-0319-9.","journal-title":"Nat Rev Clin Oncol"},{"key":"4995_CR33","doi-asserted-by":"publisher","first-page":"4995","DOI":"10.1158\/0008-5472.CAN-24-3393","volume":"85","author":"T Haykal","year":"2025","unstructured":"Haykal T, Yang R, Tohme C, He Z, Liu S, Geller DA, et al. Surgery-Induced Neutrophil Extracellular Traps Promote Tumor Metastasis by Reprogramming Cancer Cell Lipid Metabolism. Cancer Res. 2025;85:4995\u20135014. https:\/\/doi.org\/10.1158\/0008-5472.CAN-24-3393.","journal-title":"Cancer Res"},{"key":"4995_CR34","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s43586-022-00104-y","volume":"2","author":"BB Mendes","year":"2022","unstructured":"Mendes BB, Conniot J, Avital A, Yao D, Jiang X, Zhou X, et al. Nanodelivery of nucleic acids. Nat Rev Methods Primers. 2022;2:24. https:\/\/doi.org\/10.1038\/s43586-022-00104-y.","journal-title":"Nat Rev Methods Primers"},{"key":"4995_CR35","doi-asserted-by":"publisher","first-page":"20230115","DOI":"10.1002\/EXP.20230115","volume":"5","author":"Q Guo","year":"2025","unstructured":"Guo Q, Xu X, Lai X, Duan J, Yan D, Wang D. Antigen\/adjuvant-free liposome induces adjuvant effects for enhancing cancer immunotherapy. Exploration. 2025;5:20230115. https:\/\/doi.org\/10.1002\/EXP.20230115.","journal-title":"Exploration"},{"key":"4995_CR36","doi-asserted-by":"publisher","first-page":"100054","DOI":"10.1016\/j.ntm.2024.100054","volume":"3","author":"MM Shehata","year":"2024","unstructured":"Shehata MM. Anticancer lipid-based drug delivery systems: Basic knowledge and recent applications. Nano TransMed. 2024;3:100054. . https:\/\/doi.org\/10.1016\/j.ntm.2024.100054","journal-title":"Nano TransMed"},{"key":"4995_CR37","doi-asserted-by":"publisher","first-page":"2313791","DOI":"10.1002\/adma.202313791","volume":"36","author":"A Vaidya","year":"2024","unstructured":"Vaidya A, Moore S, Chatterjee S, Guerrero E, Kim M, Farbiak L, et al. Expanding RNAi to Kidneys, Lungs, and Spleen via Selective ORgan Targeting (SORT) siRNA Lipid Nanoparticles. Adv Mater. 2024;36:2313791. https:\/\/doi.org\/10.1002\/adma.202313791.","journal-title":"Adv Mater"},{"key":"4995_CR38","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nature02580","volume":"429","author":"P Oh","year":"2004","unstructured":"Oh P, Li Y, Yu J, Durr E, Krasinska KM, Carver LA, et al. Subtractive proteomic mapping of the endothelial surface in lung and solid tumours for tissue-specific therapy. Nature. 2004;429:629\u201335. https:\/\/doi.org\/10.1038\/nature02580.","journal-title":"Nature"},{"key":"4995_CR39","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.1016\/j.bioactmat.2020.12.023","volume":"6","author":"T Huang","year":"2021","unstructured":"Huang T, Li S, Fang J, Li F, Tu S. Antibody-activated trans-endothelial delivery of mesoporous organosilica nanomedicine augments tumor extravasation and anti-cancer immunotherapy. Bioact Mater. 2021;6:2158\u201372. https:\/\/doi.org\/10.1016\/j.bioactmat.2020.12.023.","journal-title":"Bioact Mater"},{"key":"4995_CR40","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1038\/s41392-024-02107-5","volume":"10","author":"W Xiao","year":"2025","unstructured":"Xiao W, Jiang W, Chen Z, Huang Y, Mao J, Zheng W, et al. Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines. Signal Transduct Target Ther. 2025;10:74. https:\/\/doi.org\/10.1038\/s41392-024-02107-5.","journal-title":"Signal Transduct Target Ther"},{"key":"4995_CR41","doi-asserted-by":"publisher","first-page":"17459","DOI":"10.1021\/ja507790z","volume":"136","author":"HD Herce","year":"2014","unstructured":"Herce HD, Garcia AE, Cardoso MC. Fundamental Molecular Mechanism for the Cellular Uptake of Guanidinium-Rich Molecules. J Am Chem Soc. 2014;136:17459\u201367. . https:\/\/doi.org\/10.1021\/ja507790z","journal-title":"J Am Chem Soc"},{"key":"4995_CR42","doi-asserted-by":"publisher","unstructured":"Allolio C, Magarkar A, Jurkiewicz P, Baxov\u00e1 K, Javanainen M, Mason PE et al. Arginine-rich cell-penetrating peptides induce membrane multilamellarity and subsequently enter via formation of a fusion pore. Proc Natl Acad Sci. 2018;115:11923\u20138. https:\/\/doi.org\/10.1073\/pnas.1811520115","DOI":"10.1073\/pnas.1811520115"},{"key":"4995_CR43","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/s41568-022-00466-1","volume":"22","author":"CM Laumont","year":"2022","unstructured":"Laumont CM, Banville AC, Gilardi M, Hollern DP, Nelson BH. Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities. Nat Rev Cancer. 2022;22:414\u201330. https:\/\/doi.org\/10.1038\/s41568-022-00466-1.","journal-title":"Nat Rev Cancer"},{"key":"4995_CR44","doi-asserted-by":"publisher","first-page":"4454","DOI":"10.1038\/s41467-025-59622-4","volume":"16","author":"Y Li","year":"2025","unstructured":"Li Y, Bhargava R, Tran JT, Blane TR, Peng L, Luan F, et al. Blocking plasma cell fate enhances antigen-specific presentation by B cells to boost anti-tumor immunity. Nat Commun. 2025;16:4454. . https:\/\/doi.org\/10.1038\/s41467-025-59622-4","journal-title":"Nat Commun"},{"key":"4995_CR45","doi-asserted-by":"publisher","first-page":"3505","DOI":"10.1158\/0008-5472.CAN-10-4316","volume":"71","author":"PB Olkhanud","year":"2011","unstructured":"Olkhanud PB, Damdinsuren B, Bodogai M, Gress RE, Sen R, Wejksza K, et al. Tumor-evoked regulatory B cells promote breast cancer metastasis by converting resting CD4+ T cells to T-regulatory cells. Cancer Res. 2011;71:3505\u201315. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-4316.","journal-title":"Cancer Res"},{"key":"4995_CR46","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.ccell.2024.12.004","volume":"43","author":"W Lee","year":"2025","unstructured":"Lee W, Ko SY, Akasaka H, Weigert M, Lengyel E, Naora H. Neutrophil extracellular traps promote pre-metastatic niche formation in the omentum by expanding innate-like B cells that express IL-10. Cancer Cell. 2025;43:69\u2013e8511. https:\/\/doi.org\/10.1016\/j.ccell.2024.12.004.","journal-title":"Cancer Cell"},{"key":"4995_CR47","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nature14395","volume":"521","author":"S Shalapour","year":"2015","unstructured":"Shalapour S, Font-Burgada J, Di Caro G, Zhong Z, Sanchez-Lopez E, Dhar D, et al. Immunosuppressive plasma cells impede T cell-dependent immunogenic chemotherapy. Nature. 2015;521:94\u20138. https:\/\/doi.org\/10.1038\/nature14395.","journal-title":"Nature"},{"key":"4995_CR48","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/intimm\/dxw007","volume":"28","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Morgan R, Chen C, Cai Y, Clark E, Khan WN, et al. Mammary-tumor-educated B cells acquire LAP\/TGF-\u03b2 and PD-L1 expression and suppress anti-tumor immune responses. Int Immunol. 2016;28:423\u201333. https:\/\/doi.org\/10.1093\/intimm\/dxw007.","journal-title":"Int Immunol"},{"key":"4995_CR49","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/nature12979","volume":"507","author":"P Shen","year":"2014","unstructured":"Shen P, Roch T, Lampropoulou V, O\u2019Connor RA, Stervbo U, Hilgenberg E, et al. IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases. Nature. 2014;507:366\u201370. https:\/\/doi.org\/10.1038\/nature12979.","journal-title":"Nature"},{"key":"4995_CR50","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/nm.3554","volume":"20","author":"R-X Wang","year":"2014","unstructured":"Wang R-X, Yu C-R, Dambuza IM, Mahdi RM, Dolinska MB, Sergeev YV, et al. Interleukin-35 induces regulatory B cells that suppress autoimmune disease. Nat Med. 2014;20:633\u201341. https:\/\/doi.org\/10.1038\/nm.3554.","journal-title":"Nat Med"},{"key":"4995_CR51","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1158\/2326-6066.CIR-19-0349","volume":"8","author":"B Mirlekar","year":"2020","unstructured":"Mirlekar B, Michaud D, Lee SJ, Kren NP, Harris C, Greene K, et al. B cell\u2013derived IL35 drives STAT3-dependent CD8\u2009+\u2009T-cell exclusion in pancreatic cancer. Cancer Immunol Res. 2020;8:292\u2013308. https:\/\/doi.org\/10.1158\/2326-6066.CIR-19-0349.","journal-title":"Cancer Immunol Res"},{"key":"4995_CR52","doi-asserted-by":"publisher","first-page":"eaan3464","DOI":"10.1126\/scitranslmed.aan3464","volume":"10","author":"JA Krall","year":"2018","unstructured":"Krall JA, Reinhardt F, Mercury OA, Pattabiraman DR, Brooks MW, Dougan M, et al. The systemic response to surgery triggers the outgrowth of distant immune-controlled tumors in mouse models of dormancy. Sci Transl Med. 2018;10:eaan3464. https:\/\/doi.org\/10.1126\/scitranslmed.aan3464.","journal-title":"Sci Transl Med"},{"key":"4995_CR53","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1158\/0008-5472.CAN-12-1993","volume":"73","author":"L-H Tai","year":"2013","unstructured":"Tai L-H, De Souza CT, B\u00e9langer S, Ly L, Alkayyal AA, Zhang J, et al. Preventing postoperative metastatic disease by inhibiting surgery-induced dysfunction in natural killer cells. Cancer Res. 2013;73:97\u2013107. https:\/\/doi.org\/10.1158\/0008-5472.CAN-12-1993.","journal-title":"Cancer Res"},{"key":"4995_CR54","doi-asserted-by":"publisher","first-page":"eaar1916","DOI":"10.1126\/scitranslmed.aar1916","volume":"10","author":"CG Park","year":"2018","unstructured":"Park CG, Hartl CA, Schmid D, Carmona EM, Kim H-J, Goldberg MS. Extended release of perioperative immunotherapy prevents tumor recurrence and eliminates metastases. Sci Transl Med. 2018;10:eaar1916. https:\/\/doi.org\/10.1126\/scitranslmed.aar1916.","journal-title":"Sci Transl Med"},{"key":"4995_CR55","doi-asserted-by":"publisher","DOI":"10.1021\/acs.nanolett.3c05031","author":"ME Zamora","year":"2024","unstructured":"Zamora ME, Omo-Lamai S, Patel MN, Wu J, Arguiri E, Muzykantov VR, et al. A combination of physicochemical tropism and affinity moiety targeting of lipid nanoparticles enhances organ targeting. Nano Lett. 2024. https:\/\/doi.org\/10.1021\/acs.nanolett.3c05031. acs.nanolett.3c05031.","journal-title":"Nano Lett"},{"key":"4995_CR56","doi-asserted-by":"publisher","first-page":"2417101","DOI":"10.1002\/adfm.202417101","volume":"35","author":"Y Liu","year":"2025","unstructured":"Liu Y, Zhang R, Qiu N, Wang S, Chen J, Xu X, et al. Spleen-Targeted mRNA Nanoparticles for Modulating B Cell Hyperactivation in Rheumatoid Arthritis Therapy. Adv Funct Mater. 2025;35:2417101. https:\/\/doi.org\/10.1002\/adfm.202417101.","journal-title":"Adv Funct Mater"},{"key":"4995_CR57","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/s41423-023-01110-0","volume":"21","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Jiang H, Yang N, Shen S, Huang D, Jia L, et al. Glioma-derived ANXA1 suppresses the immune response to TLR3 ligands by promoting an anti-inflammatory tumor microenvironment. Cell Mol Immunol. 2023;21:47\u201359. https:\/\/doi.org\/10.1038\/s41423-023-01110-0.","journal-title":"Cell Mol Immunol"},{"key":"4995_CR58","doi-asserted-by":"publisher","first-page":"425","DOI":"10.3390\/cells12030425","volume":"12","author":"S Sandri","year":"2023","unstructured":"Sandri S, Hebeda CB, Broering MF, De Paula Silva M, Moredo LF, De Barros E, Silva MJ, et al. Role of Annexin A1 Secreted by Neutrophils in Melanoma Metastasis. Cells. 2023;12:425. https:\/\/doi.org\/10.3390\/cells12030425.","journal-title":"Cells"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-026-04995-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04995-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-026-04995-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T05:31:44Z","timestamp":1788154304000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-026-04995-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,29]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4995"],"URL":"https:\/\/doi.org\/10.1186\/s12951-026-04995-x","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,29]]},"assertion":[{"value":"24 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Female BALB\/c and C57BL\/6J mice aged 6\u20138 weeks were obtained from SiPeiFu (Beijing, China). Female mice were used to establish the breast cancer model. Sex influence was not evaluated as breast cancer predominantly affects females. All procedures were approved by the First Affiliated Hospital of Zhengzhou University Animal Care and Use Committee (approval No. 2021-KY-0634-001).","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"822"}}